SCHEMBL16018193

SCHEMBL16018193

CCc1coc(CC)c1C(=O)Nc1ccc(-c2cc3c(cc2C)OC(F)(F)O3)cn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 6/20 0.50
▸ ORAI1 Q96D31 6/20 0.50
▸ ORAI2 Q96SN7 1/20 0.43
▸ IL2 P60568 1/20 0.40
▸ SCN9A Q15858 1/20 0.38
▸ POLQ O75417 1/20 0.37
▸ KIT P10721 2/20 0.36
▸ BRAF P15056 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ AKT1 P31749 2/20 0.36
▸ KDR P35968 2/20 0.36
▸ ABL1 P00519 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16018215 0.91 STIM1 (0.51) STIM1ORAI1ORAI2IL2SCN9A
SCHEMBL16018227 0.90 STIM1 (0.49) STIM1ORAI1ORAI2IL2KIT
SCHEMBL16017276 0.87 STIM1 (0.39) STIM1ORAI1ORAI2IL2SCN9A
SCHEMBL16018229 0.87 STIM1 (0.54) STIM1ORAI1ORAI2IL2
SCHEMBL16020574 0.84 STIM1 (0.49) STIM1ORAI1ORAI2IL2SCN9A
SCHEMBL16018175 0.83 STIM1 (0.52) STIM1ORAI1ORAI2IL2SCN9A
SCHEMBL16018185 0.82 STIM1 (0.51) STIM1ORAI1ORAI2IL2POLQ
SCHEMBL16018162 0.82 STIM1 (0.52) STIM1ORAI1ORAI2IL2SCN9A
SCHEMBL14885669 0.81 STIM1 (0.50) STIM1ORAI1ORAI2ALDH1A1CYP2C9
SCHEMBL1701956 0.80 STIM1 (0.66) STIM1ORAI1ORAI2IL2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856240-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2018-01-02 — — US disclosed
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2014-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885ORAI2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback